Must Capital Inc V.MUST.H

RE:RE:This ceo is truly a scam artist in my opinion

[illumination1]

well he will have his time to address the shareholders and to explain things as to what is going on. Derek, do you know why bigger pharma companies buy smaller ones? The reason my friend is that doing the r&d is extremely costly and big pharma doesn't want to pay to go through the phases so as to avoid putting at risk their cash but would rather have the smaller companies to cover all the costs. Guess what, many times the companies will be heavy in the red this is just the way it is so being $17 million in the red isn't something which is uncommon for a company to be in--quite honestly it isn't all that bad. As far as the post you're talking about yes, it looks like the link doesn't work and that definitely doesn't look good but maybe that link was removed prior to them reading the board or if you are sure it was working than maybe they are reading the boards--regardless I am sure that the CEO has to address everyone here and present his side of the story as for right now what we have is your's and as I have said what you are sharing is obviously true but what is missing is the other relevant context to get a fuller and more accurate picture. Is it possible that you are working to some capacity for Vitera and are afraid as long as this company is getting access to money via the primary market selling to us to the retailer for a profit after buying ifd shares will cause Vitera problems and competition. Apparently, it doesn't seem like Vitera is head and shoulders better than this one but seems more or less comparable in many ways including the quality of effectiveness in efficacy. In any case, I will wait for the CEO to address all of us and don't have any immediate plans to drop any shares as I don't strongly believe anyone has to worry in regards to the intellectual front--again, the FDA wouldn't give approval if ifd's design contravened Vitera's. glta